HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
$3.02
Makalipas ang Oras ng Trabaho:(1.99%)+0.060
$3.08
Sarado: Set 12, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.14
Sakop ng araw
$2.95 - $3.08
Sakop ng taon
$1.78 - $8.56
Market cap
63.37M USD
Average na Volume
91.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 12.73M | -19.47% |
Net na kita | -49.19M | -61.29% |
Net profit margin | — | — |
Kita sa bawat share | -2.34 | -162.92% |
EBITDA | -49.32M | -54.38% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 44.40M | -74.46% |
Kabuuang asset | 96.18M | -62.10% |
Kabuuang sagutin | 116.40M | 35.70% |
Kabuuang equity | -20.22M | — |
Natitirang share | 20.98M | — |
Presyo para makapag-book | -3.27 | — |
Return on assets | -106.60% | — |
Return on capital | -130.10% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -49.19M | -61.29% |
Cash mula sa mga operasyon | -38.77M | -95.36% |
Cash mula sa pag-invest | 31.90M | 1,471.04% |
Cash mula sa financing | 120.00K | 203.45% |
Net change in cash | -6.74M | 69.74% |
Malayang cash flow | -19.80M | -35.25% |
Tungkol
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Itinatag
Ene 1, 2006
Headquarters
Website
Mga Empleyado
155
